'Fantastic,' 'Terrific' Results With Oncolytic Virus Combo for Bladder Cancer

(MedPage Today) -- CHICAGO -- An oncolytic virus therapy combined with pembrolizumab (Keytruda) produced complete responses (CRs) in 85% of patients with bacillus Calmette-Guérin (BCG)-unresponsive non-muscle-invasive bladder cancer (NMIBC...
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news